Bao-Hong Zhang Founder of Epigenic Therapeutics Backed byQiming Venture PartnersChen Liwen LinkedIn SourcesEpigenic Therapeutics Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic Medicines — 2025-09 Browse all founders · Browse investors
